secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001999371-24-004225
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix announces $4.4M offering at $0.30 per share; lowers existing warrant exercise prices to $0.33
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.4M from sale of 14.7M shares and 14.7M Series E warrants at $0.30 combined price.
- Series E warrants exercisable at $0.33, begin 6 months from issuance, expire in 5.5 years.
- Existing warrants from Aug/Oct/Dec 2023 amended to exercise price $0.33 and extended expiration dates, subject to shareholder approval.
- Proceeds to be used for working capital, general corporate purposes, and to satisfy a portion of debt.
- Closing expected April 1, 2024; A.G.P./Alliance Global Partners acts as placement agent with 7% fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000199937124004225/0001999371-24-004225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000199937124004225/tnxp_8k-032824.htm
  HTML page:      https://secwatch.observer/filing/0001999371-24-004225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer